Brief: Lifespot Health Appoints Matthew Golden As CEO
12/10/2020 01:36
Oct 12 (Reuters) - Lifespot Health Ltd LSH.AX :
* CEO APPOINTMENT-LSH.AX
* MATTHEW GOLDEN APPOINTED CHIEF EXECUTIVE OFFICER
Source text for Eikon: ID:nAZN00GIAJ
Further company coverage: LSH.AX
(Reporting by Yamini C S)
((Yamini.CS@thomsonreuters.com;))
Recent news on Nexalis Therapeutics
See all newsBrief: Nexalis Therapeutics Says Sean Williams Has Resigned As Non-Executive Chairman
Brief: Nexalis Therapeutics Signs Funding Partnership With Point8 Capital To Replace Existing Facility
Brief: Nexalis Therapeutics Seeks Trading Halt
Brief: Nexalis Therapeutics Says US Policy Market Advancement Supports SRX-25 TRD Treatment
Australia's Nexalis Therapeutics gains most in over 6 months on trial approval